Showing results (641-650 of 718) with videos related to
Sort By:
Pageof 72
Journal of the American Chemical Society|October 18, 2013
Geometric and electronic structure of the Mn(IV)Fe(III) cofactor in class Ic ribonucleotide reductase: correlation to the class Ia binuclear non-heme iron enzymeYeonju Kwak, Wei Jiang, Laura M K Dassama, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trialA S Mansfield, A Każarnowicz, N Karaseva, et al.Future Oncology (London, England)|February 13, 2024
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusionsDong-Wan Kim, Alison M Schram, Antoine Hollebecque, et al.JCO Precision Oncology|December 27, 2021
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 SkippingXiuning Le, Lingzhi Hong, Chuck Hensel, et al.The Oncologist|August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case SeriesJacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.Cancer Immunology Research|January 26, 2024
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with CancerHewitt Chang, Jaqueline Marquez, Brandon K Chen, et al.Journal of Neuroimmunology|October 12, 2016
Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4Mario A Pulido, Meleeneh Kazarian DerHartunian, Zhenxia Qin, et al.Circulation Research|October 13, 2007
Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemiaMarta Bosch-Marce, Hiroaki Okuyama, Jacob B Wesley, et al.American Journal of Clinical Oncology|February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 StudyRoger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.Pageof 72